TrialDrug design, development and therapy2015

Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy in adults with Fabry disease.

Lubor Goláň et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.